Answers are grounded in this paper and cite their sources.
Noncompliance is an important issue in the design and conduct of randomized controlled trials (RCTs). It arises when participants do not receive the treatment or intervention to which they were randomly allocated. For example, some participants invited to go through a screening program may not
No takes yet. Share an insight, caveat, or question.
Catherine Hewitt (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: